In vivo vascular damage, leukocyte activation and inflammatory response induced by β-amyloid

Journal of Submicroscopic Cytology and Pathology

Volumn 29, Issue 3, 1997, Pages 293-304

  Thomas, T ^a,b   Sutton, E T ^a   Bryant, M W ^a   Rhodin, J A G ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Woodlands Med and Research Center   (United States)

Author keywords

amyloid; Alzheimer's disease; Amyloid angiopathy; Antioxidants; Inflammatory response; Intravital microscopy

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ELECTRON MICROSCOPY; INFLAMMATION; LEUKOCYTE; MALE; MESENTERY; MICROCIRCULATION; MICROSCOPY; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ENDOTHELIUM, VASCULAR; INFLAMMATION; LEUKOCYTES; MALE; MESENTERY; MICROCIRCULATION; MICROSCOPY, ELECTRON; MICROSCOPY, VIDEO; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031179444     PISSN: 11229497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. ANDERSEN K., LAUNER L.J., OTT A., HOES A.W., BRETELER M.M.B. and HOFMAN A., 1995. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology, 45, 1441-1445.
2. BLASS J.P., 1993. Pathophysiology of Alzheimer's syndrome. Neurology, 43, S25-S38.
3. BUEE L., HOF P.R., BOURAS C., DELACOURTE A., PERL D.P., MORRISON J.H. and FILLIT H.M., 1994. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementia disorders. Acta Neuropathol. (Berlin), 87, 469-480.
4. CHEN M., INESTROSA N.C., ROSS R.S. and FERNANDEZ H.L., 1995. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem. Biophys. Res. Commun., 213, 96-103.
5. DUFF K., ECKMAN C., ZEHR C., YU A., PRADA C.-M., PEREZ-TUR J., HUTTON M., BUEE L., HARIGAYA Y., YAGER D., MORGAN D., GORDON M.N., HOLCOMB L., REFOLO L., ZENK B., HARDY J. and YOUNKIN S., 1996. Increased amyloid-β-42(43) in brains of mice expressing mutant presenilin 1. Nature, 383, 710-713.
6. CLAUDIO L., 1996. Ultrastructural features of the blood-brain barrier in the biopsy tissue from Alzheimer's disease patients. Acta Neuropathol. (Berlin), 91, 6-14.
7. EDELBERG H.K. and WEI J.Y., 1996. The biology of Alzheimer's disease. Mech. Ageing Dev., 91, 95-114.
8. GHISO J., WISNIEWSKI T.A. and FRANGIONE B., 1994. Unifying features of systemic and cerebral amyloidosis. Mol. Neurobiol., 8, 49-64.
9. HOFMAN A., OTT A., BRETELER M.M.B., BOTS M.L., SLOOTER A.J.C., VAN HARSKAMP F., VAN DUIJN C.N., VAN BROECKHOVEN C. and GROBBEE D.E., 1997. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet, 349, 151-154.
10. HÜLL M., FIEBICH L., LIEB K., STRAUSS S., BERGER M., VOLK B. and BAUER J., 1996. Interleukin-6-associated inflammatory processes in Alzheimer's disease: New therapeutic options. Neurobiol. Ageing, 17, 795-800.
11. KALARIA R.N., 1996. Cerebral vessels in aging and Alzheimer's disease. Pharmacol. Ther., 72, 193-214.
12. KALARIA R.N. and HEDERA P., 1995. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. NeuroReport, 6, 477-480.
13. KALARIA R.N. and HEDERA P., 1996. Beta-amyloid vasoactivity in Alzheimer's disease. Lancet, 347, 1492-1493.
14. LORTON D., KOCSIS J.M., KING L., MADDEN K. and BRUNDEN K.R., 1996. β-Amyloid induces increased release of interleukin-1 beta from lipopolysaccharide-activated human monocytes. J. Neuroimmunol., 67, 21-29.
15. MARTEL C.L., MACKIC J.B., MCCOMB J.G., GHISO J. and ZLOKOVIC B.V., 1996. Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulatory Alzheimer's amyloid beta in guinea pigs. Neurosci. Lett., 206, 157-160.
16. MATTSON M.P. and RYDELL R.E., 1996. Alzheimer's disease. Amyloid ox-tox transducers. Nature, 382, 674-675.
17. MAYHAN W.G., FARACI F.M., BAUMBACH G.L. and HEISTAD D.D., 1990. Effects of aging on responses of cerebral arterioles. Am. J. Physiol., 258, H1138-H1143.
18. MAYROVITZ H.N., TUMA R.F. and WIEDEMANN M.P., 1980. Leukocyte adherence in arterioles following extravascular tissue trauma. Microvasc. Res., 20, 264-274.
19. MEYER J.S., SHIRAI T. and AKIYAMA H., 1996. Neuroimaging for differentiating vascular changes from Alzheimer's dementias. Cerebrovasc. Brain Metab. Rev., 8, 1-10.
20. MILLER D.L., PAPAYANNOPOULOS I.A., STYLES J., BOBIN S.A., LIN Y.Y., BIEMANN K. and IQBAL K., 1993. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys., 301, 41-52.
21. PODLISNY M.B., TOLAN D.R. and SELKOE D.J., 1991. Homology of the amyloid beta protein precursor in monkey and human supports of a primate model for beta amyloidosis in Alzheimer's disease. Am. J. Pathol., 138, 1423-1435.
22. RHODIN J.A.G. and FUJITA H., 1989. Capillary growth in the mesentery of normal young rats. Intravital video and electron microscope analysis. J. Submicrosc. Cytol. Pathol., 21, 1-34.
23. RHODIN J.A.G. and LAMETSCHWANDTNER A., 1993. Circulatory pattern and structure in the tail and tail fins of Xenopus laevis tadpoles. J. Submicrosc. Cytol. Pathol., 25, 297-318.
24. ROSEN D., MARTIN-MORRIS L., LUO L.Q. and WHITE K., 1989. A Drosophila gene encoding a protein resembling the human β-amyloid protein precursor. Proc. Natl. Acad. Sci. USA, 86, 2478-2482.
25. ROSES A.D., 1994. Apolipoprotein E effects the rate of Alzheimer's disease expression: beta-amyloid protein is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol., 53, 429-437.
26. SCHEIBEL A.B., DUONG T.H. and TOMIYASU U., 1987. Denervation microangiopathy in senile dementia, Alzheimer type. Alzheimer's Dis. Assoc. Disord., 1, 19-37.
27. SELKOE D.J., 1994. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell. Biol., 10, 373-403.
28. SIMPSON I.A., CHUNDU K.R., DAVIS-HILL T., HONER W.G. and DAVIES P., 1994. Decreased concentrations of GLUT 1 and GLUT 3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol., 35, 546-551.
29. SPARKS D.L., 1997. Coronary artery disease, hypertension, APOE, a link to AD? Ann. N.Y. Acad. Sci. (in press).
30. SPARKS D.L., SCHEFF S.W., LIU H., LANDERS T., DANNER F., COYNE C.M. and HUNSAKER III J.C., 1996. Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients. J. Neurol. Sci., 138, 97-104.
31. STAMLER J.S., 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell, 78, 931-936.
32. STEWART P.A., HAYAKAWA K., AKERS M.A. and WINTERS H.V., 1992. A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab. Invest., 67, 734-742.
33. SUENAGA T., OHNISHI K., NISHMURA M., NAKAMURA S., AKIGUCHI I. and KIMURA J., 1994. Bundles of amyloid precursors proteins-immunoreactive axons in human cerebrovascular white matter lesions. Acta Neuropathol. (Berlin), 87, 450-455.
34. SUTTON E.T., HELLERMAN G.R. and THOMAS T., 1997. β-amyloid induced endothelial necrosis and inhibition of nitric oxide production. Exp. Cell Res., 230, 368-376.
35. THOMAS T., THOMAS G., MCLENDON C., SUTTON E.T. and MULLAN M., 1996. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature, 380, 168-171.
36. THOMAS T., MCLENDON C., SUTTON E.T. and THOMAS G., 1997. Cerebrovascular endothelial dysfunction mediated by β-amyloid. NeuroReport, 8, 1387-1391.
37. WISNIEWSKI T., LALOWSKI M., LEVY E., MARGUES M.R. and FRANGIONE B., 1994. The amino acid sequence of neuritic amyloid from a familial Alzheimer's disease patient. Ann. Neurol., 35, 245-246.
38. WOLFE N., REED B.R., EBERLING J.L. and JAGUST W.J., 1995. Temporal lobe perfusion on single photon emission computed tomography predicts the rate of cognitive decline in Alzheimer's disease. Arch. Neurol., 52, 257-262.
39. YAN S.D., CHEN X., FU J., CHEN M., ZHU H., ROHER A., SLATTERY T., ZHAO L., NAGASHIMA M., MORSER J., MIGHELI A., NAWROTH P., STERN D. and SCHMIDT A.M., 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's diseases. Nature, 382, 685-691.
40. YAMADA M., ITOH Y., SHINTAKU M., KAWAMURA J., JENSSON O., THORSTEINSSON L., SUEMATSU N., MATSUSHITA M. and OTOMO E., 1996. Immune reactions associated with cerebral amyloid angiopathy. Stroke, 27, 1155-1162.
41. YAMAUCHI H., FUKUYAMA H., HARADA K., NABATAME H., OGAWA M., OUCHI Y., KIMURA J. and KONISH J., 1993. Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease. Arch. Neurol., 50, 1070-1075.
42. YAMASHITA K., MIYAKAWA T. and KATSURAGI S., 1991. Vascular changes in the brains with Alzheimer's disease. Jpn. J. Psychiatry Neurol., 45, 79-84.
43. ZLOKOVIZ B.V., 1996. Cerebrovascular transport of Alzheimer's amyloid β and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier. Life Sci., 59, 1483-1497.